RecruitingNot ApplicableNCT05124808

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Mellitus: A Multicenter Randomized Trial

Sponsor

Indiana University

Enrollment

828 participants

Start Date

Mar 1, 2022

Study Type

INTERVENTIONAL

Conditions

Overweight and Obesity Gestational Diabetes Pregnancy, High Risk

Summary

This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Intensive glycemic targets and Standard glycemic targets for people with gestational diabetes, overweight and obesity, and other related conditions. The study is currently recruiting participants at 5 locations. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERIntensive glycemic targets

Fasting blood glucose \<90 mg/dL, 1 hour post-prandial blood glucose \<120 mg/dL

OTHERStandard glycemic targets

Fasting blood glucose \<95 mg/dL, 1 hour post-prandial blood glucose \<140 mg/dL

Locations(5)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Indiana University

Indianapolis, Indiana, United States

University of Oklahoma

Norman, Oklahoma, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Women and Infants Hospital of Rhode Island

Providence, Rhode Island, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05124808

Related Trials

Validity and Reliability of Mixed Reality-Based Performance Tests in Overweight and Obese Adults

NCT076544391 location

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

NCT053164931 location